My research focuses on why patients with the same type of cancer can respond very differently to the same treatment. One key reason appears to be the body’s own defense system

My PhD research focuses on understanding how cancer cells evolve during treatment, particularly how they become resistant to targeted therapies over time. I study a type of childhood cancer called ALK-positive Anaplastic Large Cell Lymphoma

My research focuses on understanding how and why people get cancer. Specifically, I study two subtypes of a rare immune cell cancer called Anaplastic Large Cell Lymphoma (ALCL). In this disease, T cells that are usually protecting the body

My research is about a cancer called ALCL, which affects immune cells known as T-cells. These cells normally help your body fight infections, but in this disease they accumulate genetic errors and start multiplying uncontrollably

Most people think cancer is just about the tumor itself, a mass of “bad” cells growing out of control. But that’s only part of the story. What I study is everything around the tumor – the immune cells trying to fight it, the surrounding support cells

My research focuses on a type of cancer called anaplastic large cell lymphoma (ALCL), which comes from T cells—immune cells that normally protect the body from infections. In healthy conditions

In my PhD work we are investigating a rare type of T cell lymphoma occuring mostly in children and young adults. We are investigating what happens when a patient stops responding to therapy